| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP&Pres, Periph Intervent | SVP&Pres, Periph Intervent
1 company
Mirviss Jeffrey B. is an EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $1.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2025 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 7,363 | $104.16 | $766,920.75 | -12.0% | +5.4% | -27.0% | |
| Feb 19, 2025 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 1,510 | $105.35 | $159,078.50 | -4.4% | +0.8% | -28.3% | |
| Feb 12, 2025 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 13,022 | $105.06 | $1,368,073.09 | -31.4% | -2.7% | -29.9% | |
| Jan 3, 2025 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 7,152 | $89.86 | $642,657.98 | -20.1% | +8.6% | +4.4% | |
| May 29, 2024 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 63,802 | $75.10 | $4,791,447.26 | -69.5% | +6.5% | +39.4% | |
| Mar 18, 2024 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 14,506 | $66.45 | $963,929.50 | -20.0% | +13.3% | +47.6% | |
| Feb 21, 2024 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 4,960 | $66.35 | $329,096.00 | -6.4% | +15.1% | +60.2% | |
| Jan 9, 2024 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 15,172 | $59.25 | $898,941.00 | -21.1% | +16.0% | +62.0% | |
| Jan 4, 2024 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sale+OE | 15,000 | $58.40 | $876,001.50 | -21.0% | +17.1% | +55.9% | |
| Jan 3, 2024 | BSX Boston Scientific Corp | EVP&Pres, Periph Intervent | Sell | 11,931 | $57.82 | $689,862.35 | -17.4% | +17.1% | +55.2% |